New vaccine aims to stop Virus-Linked cancers in organ transplant patients
NCT ID NCT06741072
First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This early-stage trial tests a vaccine called OSU-2131, designed to help the immune system fight Epstein-Barr virus (EBV). EBV can cause cancers in people who have weakened immune systems, such as those awaiting organ transplants. The study includes healthy volunteers and transplant candidates to see if the vaccine is safe and triggers an immune response.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- OSU-2131 (a peptide vaccine) with QS-21 adjuvant
- What this could lead to
- If it works, this could lead to a vaccine that prevents EBV-related cancers in transplant patients.
- What could go wrong
- This is a very early phase 1 trial focused on safety, so it may not prove effective. The study is currently suspended, and results are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE STAGE 4 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Ohio State University Comprehensive Cancer Center
RECRUITINGColumbus, Ohio, 43210, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI therapy coach aims to ease distress in seriously ill seniors
- A softer path for kidney disease: could palliative care ease the burden?
- Can a new drug combo shield young hearts from transplant complications?
- Thousands of kidney patients tracked to unlock better disease management
- Gut health supplement may calm inflammation in kidney dialysis patients
- Why kidney disease drains your strength: scientists probe muscle fatigue